Latest Financial Health News

Atomos Limited has posted its first positive EBITDA quarter since late 2022, driven by strong sales of its flagship Ninja and Shinobi products. The company’s operational overhaul and strategic product launches set the stage for continued growth into Q2 FY26.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

XPON Technologies reports a robust Q1 FY26 with 17.5% revenue growth, positive cash flow, and strategic leadership changes, setting a strong foundation for the year ahead.

Syntara Limited reports encouraging Phase 2a results for amsulostat in myelofibrosis, with significant symptom relief and spleen volume reduction sustained over 12 months, alongside new clinical trial initiations and a solid cash position.

Coronado Global Resources has proposed a significant financial support transaction with Stanwell Corporation, aiming to enhance liquidity, extend coal supply agreements, and support Queensland’s energy needs and local employment.

Coast Entertainment’s Dreamworld development application has been called-in by the Queensland Minister, while the company reports robust FY26 trading growth and nears completion of its new King Claw ride.

Mt Malcolm Mines NL has announced a $2.3 million renounceable rights issue priced at 1.5 cents per share, aiming to fund exploration and development at its Malcolm Gold Project while strengthening its financial position.

OpenLearning Limited reports a strong Q3 FY25 with SaaS ARR up 27% year-on-year and a successful $2.6 million capital raise, positioning the company for cash flow breakeven within 18 months.

AnteoTech Ltd reports strong quarterly progress with a key US joint development agreement, significant manufacturing scale-up, and expanded market access in South Korea, underpinning its 2025 commercialisation strategy.

AML3D Limited reported steady quarterly receipts alongside a landmark US Navy Letter of Intent and significant orders, underpinning a major growth phase in the US and Europe.

Nova Minerals has secured a significant US$43.4 million funding award from the U.S. Department of War to accelerate its Estelle Project in Alaska, advancing both gold and antimony development with strong government backing and infrastructure progress.